Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.5600
-0.0130 (-2.27%)
Aug 1, 2025, 4:00 PM - Market closed
Altus Power Revenue
Xtant Medical Holdings had revenue of $32.90M in the quarter ending March 31, 2025, with 18.05% growth. This brings the company's revenue in the last twelve months to $122.30M, up 20.81% year-over-year. In the year 2024, Xtant Medical Holdings had annual revenue of $117.27M with 28.44% growth.
Revenue (ttm)
$122.30M
Revenue Growth
+20.81%
P/S Ratio
0.62
Revenue / Employee
$527,147
Employees
232
Market Cap
78.02M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 117.27M | 25.96M | 28.44% |
Dec 31, 2023 | 91.30M | 33.33M | 57.50% |
Dec 31, 2022 | 57.97M | 2.71M | 4.90% |
Dec 31, 2021 | 55.26M | 1.93M | 3.61% |
Dec 31, 2020 | 53.34M | -11.35M | -17.54% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
XTNT News
- 25 days ago - Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine - PRNewsWire
- 2 months ago - Xtant Medical Announces the Launch of OsteoFactor Pro™ - PRNewsWire
- 2 months ago - Xtant Medical Holdings, Inc. (XTNT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Xtant Medical Reports First Quarter 2025 Financial Results - PRNewsWire
- 3 months ago - Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025 - PRNewsWire
- 3 months ago - Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance - PRNewsWire
- 3 months ago - Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19% - PRNewsWire
- 5 months ago - Xtant Medical Holdings, Inc. (XTNT) Q4 2024 Earnings Call Transcript - Seeking Alpha